Sign inJoin waitlistJoin the waitlist

Antonio Saad

Program Director, Maternal-Fetal Medicine Fellowship · Inova Fairfax Hospital Campus

Credentials: · · ·

History

Maternal-Fetal Medicine Fellowship · Inova Fairfax Hospital Campus
Present
University of Texas Medical Branch Hospitals
Present

Critical Care Medicine
University of Texas Medical Branch Hospitals
2009–2010
Obstetrics and Gynecology
University of Texas Medical Branch Hospitals
2007–2009
General Surgery
University of Southern California/Los Angeles General Medical Center
2004–2007
University of Houston C.T
American University of Beirut Faculty of Medicine
2000–2004

Research

Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer
Molecular Therapy · 2009 · 106 citations
The functional effects of acid ceramidase overexpression in prostate cancer progression and resistance to chemotherapy
Cancer Biology & Therapy · 2007 · First of 15 authors · 101 citations
OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages
Journal of Lipid Research · 2006 · First of 5 authors · 93 citations

George Saade
62 papers
Luis Pacheco
30 papers
Maged Costantine
15 papers · 8 as a resident
GH
Gary Hankins
13 papers
Garima Sharma
8 papers
SS
Scott Sullivan
8 papers
Christopher Moutos
7 papers · 7 as a resident
Marissa Berry
7 papers · 7 as a resident
Nicholas Spencer
6 papers · 5 as a resident
Amanda Wang
5 papers · 5 as a resident
Baha Sibai
5 papers
EM
Ellen Murrin
5 papers · 5 as a fellow

Clinical trials

Absorbable Staples Versus Conventional Skin Closure in Women Undergoing Cesarean Delivery
Principal investigator · Not yet recruiting
Inova Health Care Services
2026–2027
Impact of the NeuroCuple Device on Pain Management After Cesarean Delivery
Principal investigator · Recruiting
Inova Health Care Services
2025–2027
Management of Postoperative Pain After Cesarean Delivery Using Bridge Auricular Percutaneous Nerve Field Stimulator
Principal investigator · Withdrawn
Inova Health Care Services
2024–2025
Erythromycin Versus Azithromycin for Preterm Prelabor Rupture of Membranes
Principal investigator · Active not recruiting · Phase 3
Inova Health Care Services
2024–2026